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Solitary ﬁbrous tumor (SFT) is an uncommon neoplasm that usually arises from the pleura. To our knowledge, only 30 cases of
SFTs in the nasal cavity and paranasal sinuses have been reported in the literature. We describe an SFT that arose from the right
sphenoid sinus and extended to the nasal cavity and epipharynx. The tumor was completely removed by endoscopic sinus surgery
without complication. The patient is taking an uneventful course without any evidence of recurrence of the disease 8 months after
surgery now.
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1.Introduction
Solitary ﬁbrous tumor (SFT), also known as benign ﬁbrous
mesothelioma or submesothelial ﬁbroma, is an uncommon
neoplasm ﬁrst described as a primary spindle cell tumor
of the pleura in 1931 [1]. The majority of the tumors
originate from the pleura, but SFTs can also be derived from
other serosal membranes. Due to its mesenchymal origin,
SFTs have been reported to originate in a wide variety of
extrapleural locations such as the abdomen, extremities, and
vulva [2]. Recently, SFTs in the nasal cavity and paranasal
sinuses treated by endoscopic sinus surgery (ESS) have been
reported [3–8], but there are only a few reports of an SFT in
the sphenoid sinus treated by ESS. We describe an SFT that
originated in the right sphenoid sinus and extended to the
nasal cavity and epipharynx and was successfully treated by
ESS.
2.CaseReport
The patient was a 74-year-old woman with a right nasal
tumor that had caused progressive right nasal obstruction
over two years. Nasal endoscopy revealed a pinkish tumor
arising from the ostium of the right sphenoid sinus and
extending to the right nasal cavity and epipharynx (Figures
1(a) and 1(b)).
Plane-computed tomography (CT) showed a soft tissue
density in the nasal cavity, sphenoid sinus, and nasopharynx
without bone destruction on the right side. Magnetic
resonance imaging (MRI) showed a mass with a hypointense
signal on T1-weighted images (Figure 2(a)) and hetero-
geneous hypo-and hyperintense signals on T2-weighted
images (Figure 2(b)). The mass showed prominent and
inhomogeneous enhancement with gadolinium and was also
revealed to be originated from the right sphenoid sinus
(Figure 2(c)).
TheESSwasperformedundergeneralanesthesia.During
the sphenoethomoidectomy, the root of the tumor was
clearlyidentiﬁedonthelateraledgeoftheostiumoftheright
sphenoid sinus. The tumor was successfully resected “en
bloc” and was removed through the oral cavity (Figure 3).
The postoperative course has been uneventful without signs
of recurrence at eight months after surgery.
Histopathological examination of the tumor revealed
the spindle cells showing a patternless arrangement within
the collagenous matrix and numerous thick-walled vessels
with dilated vascular spaces (Figure 4(a)). Immunohisto-
chemically, the tumor cells were stained positively for CD34
(Figure 4(b)) and Bcl-2 (Figure 4(c)), but were not stained
for S-100 proteinor c-kit; thus, a diagnosis of SFT was
established.2 Case Reports in Medicine
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Figure 1: Endoscopic images of the tumor () in the right nasal cavity viewed from the superior (a) and inferior (b) directions. The base of
the tumor is seen in the lateral wall of the ostium of the sphenoid sinus (∗). ST: superior turbinate, IT: inferior turbinate, NS: nasal septum.
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Figure 2: T1- (a) and T2-weighted (b) magnetic resonance (MR) images of the tumor (). Gd-enhanced sagittal MR image (c) revealed
that the tumor originated in the right sphenoid sinus (SS).
Figure 3: Macroscopic features of the excised tumor.
3. Discussion
The ﬁrst identiﬁcation of SFT as a distinct entity is generally
credited to Klemperer and Rabin [1]. Plueral SFTs have long
been supposed to originate from the surface mesothelium
of the pleura. Today, however, most authors agree that
they originate from submesothelial connective tissue. This
hypothesisisbasedonimmunohistochemicalandultrastrac-
tural ﬁndings [9–12] as well as on the occasional occurrence
of this tumor in extrapleural sites. Histologically, SFTs are
formed by plump spindle cells arranged in a patternless
fashion in a collagenous background. Typically, there are
hyper-and hypocellular areas and prominent vascularity
within the lesion that result in a hemangiopericytoma-
like pattern. Recently, CD34, a transmembrane glycoprotein
found on the surface of hematopoietic progenitor cells,
has been considered a positive marker for SFT. Although
a varying degree of CD34 immunoreactivity is observed
in the neuroﬁbroma and schwannoma, they are usually
strongly positive also for S-100 protein, in contrast to SFT
[11].
An SFT typically presents as a slow-growing, painless
mass. To date, 30 cases of SFTs in the nasal cavity and
paranasal sinuses have been reported in the English
literature [3–8, 13–19]. Most of these patients complained of
a unilateral intranasal mass, nasal obstruction, rhinorrhea,Case Reports in Medicine 3
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Figure 4: Histopathological features of the tumor. (a) the spindle cells are arranged in a patternless fashion in the collagenous matrix
on hematoxylin-eosin staining (×200). (b) the vast majority of the tumor cells were stained diﬀusely and strongly for CD34 (×400). (c)
cytoplasm in the numerous tumor cells expressed the Bcl-2 (×400).
and epistaxis. Other signs and symptoms, such as exo-
phthalmos, epiphora, anosmia, headache, facial pain, and
visual disturbances, may also be present. In some cases, SFTs
showed bone destruction and defect on CT, but were usually
smoothly surfaced and encapsulated. In all cases of SFT,
including the present case, MRI showed iso-hypointensity
on T1-weighted images and enhancement with gadolinium
contrast. T2-weighted images varied from low intensity to
high intensity [13].
SFTs have, however, been reported to be malignant
in 13%–23% of cases. Factors associated with malignancy
include high cellularity, more than 4 mitoses per 10 high-
power ﬁelds, pleomorphism, hemorrhage, and necrosis . The
diagnosis of malignancy is based on both clinical features
and these histologic ﬁndings [2, 12, 15]. Prognostic factors
are not clearly deﬁned for SFTs in the head and neck region.
Factors that predispose to local recurrence in nonhead
and neck SFTs are a tumor diameter larger than 10cm,
the presence of a malignant component to the histologic
ﬁndings, and microscopically positive surgical margins [20].
The study by Gold et al. [20] also showed that positive
margins correlated with a large tumor. As might be expected
in the nasal cavity and paranasal sinuses, all tumors were
smaller than 10cm in diameter in head and neck SFTs. In
contrast to tumors found in other anatomic locations, such
as the trunk and lower extremities, tumors of the head and
neck lesions present a unique anatomic challenge by virtue
of their relationship to adjoining structures. Therefore, this
high rate of positive margins most likely reﬂects the tumor
location rather than its biological features. In the previous
literature, two patients were reported as local recurrence
[15, 16], but these patients were controlled by wide complete
excision. Patients with positive margins should therefore be
closely followed up for several years.
Since ESS for SFT was ﬁrst described in 2003 [3], SFTs
in the nasal cavity and paranasal sinuses have been treated
successfully by ESS [3–8] in the cases that SFT was limited in
the nasal cavity and paranasal sinuses, if there is no invasion
oftheanteriorcranialfossaandnoextensiontotheinfratem-
poralfossa.Inthepresentcase,wecouldsuccessfullytreatthe
SFT in the sphenoid sinus by ESS, because the anatomical
features of the sphenoid sinus and its surrounding structures
in terms of their relevancy for performing an endoscopic
sphenoidotomy were already clariﬁed [21].
ESS is considered the ﬁrst-line approach for achieving
the complete removal of benign tumors such as an SFT, as
long as it is delineated within the level of the nasal cavity
and paranasal sinuses except the frontal sinus. However,
the STFs extended to the skull base; these tumors should
be removed through a transcranial approach or an open
transfacial approach [13–19].
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